[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Centre Hospitalier Esquirol\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":204},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,43,69,100,127,152,176],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100649329","study-of-repetitive-behaviors-in-alzheimers-disease-100649329",false,"NCT07732842","Study of Repetitive Behaviors in Alzheimer's Disease","ECRA","Inclusion Criteria:\n\nI- RB+ (n=42) and RB- (n=30) groups :\n\n1. MMSE \\> 20\n2. 1 reliable family caregiver identified per patient\n3. Patients under legal protection (guardianship\u002Fcuratorship) or not\n4. Selection:\n\n4.a. AD patients with an SRI score \\> 0 will constitute the RB+ subgroup. 4.b. Only the first 30 patients included will undergo V2, V3, and V4. The first 30 AD patients included with an SRI score = 0 will constitute the RB- subgroup.\n\nII- Control group: healthy subjects (n=30)\n\n1. Healthy subjects\n2. MMSE ≥ 26\u002F30\n3. Men and women matched to AD patients in terms of age and sociocultural level.\n4. Healthy subjects will be included by the CMRR in Limoges\n\nIII- Control group: Patient with anterograde amnesia (AA) (n=1):\n\n1. The patient with anterograde amnesia is a patient who participated in the ANISAAFORNIX study (another study submitted by the investigator) and is included in this study due to rich RB symptomatology. He is a 54-year-old man with lesions of the fornix following complications from neurosurgery, which led to severe anterograde amnesia. This patient does not have AD.\n2. This patient is under legal protection (guardianship).\n3. Patient monitored and included at the CMRR in Limoges.\n\nExclusion Criteria: I- RB+ and RB- groups and healthy subjects:\n\n1. Isolated participants (without an identified caregiver) (RB+ and RB- groups)\n2. Participants must not have a history of alcohol or other substance dependence in the past 12 months.\n3. Participants must not have any other neurological condition (with the exception of patients with AA anterograde amnesia). Any history of moderate to severe head trauma, stroke, or developmental disorders is a criterion for exclusion.",true,"ALL","18 Years",{"count":20,"type":21},103,"ESTIMATED","OBSERVATIONAL","Alzheimer's disease (AD) is characterized by anterograde amnesia, the inability to memorize and remember events occurring after the cerebral lesion. Among the most frequently reported psycho-behavioural symptoms are repetitive behaviours (RB), defined as actions or statements repeated in an inappropriate and non-functional way.\n\nThe most commonly used tool to assess repetitive behaviours is the Stereotypy Rating Inventory (SRI). It is a questionnaire that evaluates five types of stereotypical behaviour: eating, wandering, speech, movements, and daily routines. The frequency and severity of the behaviours are reported, and a total score can be calculated.\n\nThere is no consensus on the types of repetitive behaviours observed specifically in AD, their frequency, or their cognitive correlates, nor is there a hypothesis explaining why this symptomatology does not occur in all AD patients. Furthermore, certain parameters, such as anosognosia (lack of awareness of the disorders), have not been linked to RB in the literature. We propose to evaluate patients with anterograde amnesia in terms of cognition and behaviour-specifically, the presence or absence of both RB and anosognosia-to examine possible links between cognitive performance, anosognosia, and RB.\n\nMoreover, there is no theoretical framework explaining the emergence of RB in amnesia. We suggest that CRs are linked to the lack of memory updating in the cognitive system. Since episodic memory no longer provides mnemonic feedback, previously encountered stimuli may trigger repeated behaviour.\n\nTo test this hypothesis, we decided to conduct a multicenter, cross-sectional, case-control study. Patients with AD, with or without RB, as well as healthy subjects, were repeatedly presented with sentence starters to complete freely, with the aim of studying the similarity of responses across sessions for each participant. We also included a patient with pure anterograde amnesia from a previously submitted case study protocol, who exhibited pronounced RB symptomatology following neurosurgery (non-AD patient), to examine the phenomenon in a non-Alzheimer's context.",[25,26,27],"Alzheimer Disease","Anterograde Amnesia","Anosognosia",[29],"Repetitive behavior","RECRUITING","2026-07-23",{"date":33,"type":34},"2026-07-29","ACTUAL",{"date":36,"type":34},"2021-06-24",{"date":38,"type":21},"2027-02-24",{"name":40,"class":41},"Centre Hospitalier Esquirol","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":4,"overallStatus":61,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":66,"leadSponsor":68,"locationsCount":4},"100646201","prevention-of-relapse-through-cognitive-cycling-in-patients-with-alcohol-use-disorder-following-alcohol-withdrawal-100646201","NCT07690423","Prevention of Relapse Through Cognitive Cycling in Patients With Alcohol Use Disorder Following Alcohol Withdrawal","Prevention of Relapse Through Cognitive Cycling in Patients With Alcohol Use Disorder Following Alcohol Withdrawal: Protocol for the TUA-VelCo Randomised Controlled Trial","TUA-VelCo","Inclusion Criteria:\n\n* adults aged ≥ 18 years\n* patients with a diagnosis of alcohol use disorder (AUD) according to DSM-5 criteria\n* who have been hospitalized for complex withdrawal and aim to maintain abstinence after discharge\n* patients must have preserved cognitive function, defined as a Montreal Cognitive Assessment (MoCA) score ≥ 26\n* patients must provide written informed consent\n\nExclusion Criteria:\n\n* pregnant women\n* patients with unstable psychiatric or somatic conditions\n* with a contraindication to physical activity\n* participants in structured rehabilitation programs during the first month\n* adult under guardianship\n* with inability to understand French or provide informed consent\n* with major neurocognitive disorder\n* with regular physical activity\n* participation in another interventional study interfering with outcomes",{"count":52,"type":21},128,"INTERVENTIONAL",[55],"NA","TUA-VelCo is a single-center randomized controlled superiority trial with blinded methodological assessment. Adult patients hospitalized for alcohol withdrawal and meeting the criteria for Alcohol Use Disorder (AUD) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition will be eligible for inclusion. Participants will be randomly assigned to either a cognitive cycling intervention group or a control group.\n\nParticipants in the experimental group will receive, in addition to standard addiction care, 12 cognitive cycling sessions (three sessions per week over four weeks). The control group will receive standard care combined with 12 scheduled telephone interviews conducted in parallel with the cognitive cycling sessions. Assessments will be conducted at baseline, 1 month (M1), and 3 months (M3) following hospital discharge.\n\nThe primary outcome will be the proportion of participants maintaining abstinence at M1. Secondary outcomes include maintenance of abstinence at M3 and within-group and between-group changes in craving, cognitive functioning, insight, psychiatric symptoms, and motivation to maintain abstinent. These outcomes will be assessed using validated scales, including the Obsessive Compulsive Drinking Scale, Montreal Cognitive Assessment, Hanil Alcohol Insight Scale, Hamilton Depression Rating Scale, and Hamilton Anxiety Rating Scale. Biomarkers related to alcohol consumption and neuroplasticity will also be evaluated.",[58,59,60],"Cognitive Cycling","Alcohol Use Disorder (AUD)","Treatment","NOT_YET_RECRUITING","2026-07-08",{"date":64,"type":34},"2026-07-10",{"date":62,"type":21},{"date":67,"type":21},"2027-12-01",{"name":40,"class":41},{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":17,"minAge":76,"maxAge":77,"enrollmentInfo":78,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":80,"conditions":81,"keywords":86,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":42},"100616444","climate-anxiety-in-a-young-population-at-risk-of-suicide-100616444","NCT07305688","Climate Anxiety in a Young Population at Risk of Suicide","Anx-RS","Inclusion Criteria:\n\n* Men and women, boys and girls ;\n* Aged between 16 and 24;\n* Participants seen in adult or pediatric emergency departments, hospitalised in adult psychiatry or in child and adolescent psychiatry, or seen in outpatient consultation at Esquirol Hospital Center ;\n* Affiliated with a social security scheme or entitled to coverage under one ;\n* Having received full information about the study and having co-signed, together with the investigator, an informed consent form to participate in the study.\n* For minor participants: the consent to participate in the study must be signed by the holder(s) of parental authority, and the minor's assent will also be required.\n\nExclusion Criteria:\n\n* Participants will not be included in the study if their health condition is incompatible with understanding or completing the questionnaires used. This includes, in particular ;\n* Any chronic somatic pathology or major sensory impairment (for example : deafness or blindness) preventing reading, comprehension or communication with healthcare professionals ;\n* Any severe psychiatric pathology that significantly impairs cognitive or communication abilities, such as acute psychotic disorders, pervasive developmental disorders or confusional states ;\n* Participants hospitalised in units specialising in severe psychiatric disorders with major impairment of cognitive functions.\n* Adults under legal protection, in accordance with article L 1121-8 of the Public Health Code ;\n* Insufficient command of the French language","16 Years","24 Years",{"count":79,"type":21},108,"Climate change has become a major source of concern, particularly among younger generations who are facing the progressive degradation of ecosystems, loss of biodiversity, and alarming environmental information disseminated through the media. The direct perception of climate-related disruptions has been shown to engender a profound sense of helplessness and loss. This distress, termed eco-anxiety, is characterised by feelings of fear, sadness and guilt regarding the planet's future.\n\nIn a context where there has been a marked increase in suicidal thoughts and attempts among young people over the past decade, it is essential to explore the psychological manifestations of eco-anxiety within this vulnerable population. The paucity of studies investigating this association underscores the significance of the present research.\n\nThe aims of this study is to examine the relationship between climate anxiety and suicidal risk among young people aged 16 to 24 years.\n\nThe study will encompass 108 young participants aged between 16 and 24 years, who are either hospitalised or receiving outpatient psychiatric care.\n\nEach participant will be required to complete one clinician-administered assessment, namely the Columbia Suicide Severity Rating Scale (C-SSRS), and two self-report questionnaires: the Climate Change Anxiety Scale - French version (CCAS-FR) and the State-Trait Anxiety Inventory (STAI-Y).\n\nFurthermore, a sociodemographic questionnaire will be administered in order to collect information regarding the subjects' age, sex, education level, living conditions, and psychiatric history.\n\nIt is hypothesised that there is a positive association between climate anxiety and suicidal risk, with the most eco-anxious participants showing higher C-SSRS scores. It is further predicted that eco-anxiety will correlate with elevated levels of state and trait anxiety, with the potential for modulating this relationship by sociodemographic factors, including gender.\n\nThis study will contribute to a better understanding of the psychological impacts of climate change on young people and help identify the most vulnerable profiles.",[82,83,84,85],"Anxiety","Suicidal Ideation","Mental Health Issue","Environmental Exposure",[87,88,89,90,91],"Eco-anxiety","Anxiety disorders","Suicide risk","Mental health","Young adults","2026-06-02",{"date":94,"type":34},"2026-06-04",{"date":96,"type":34},"2025-12-15",{"date":98,"type":21},"2027-03-15",{"name":40,"class":41},{"id":101,"slug":102,"hasResults":11,"nctId":103,"briefTitle":104,"officialTitle":105,"acronym":106,"eligibilityCriteria":107,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":108,"enrollmentInfo":109,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":111,"conditions":112,"keywords":114,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":119,"lastUpdatePostDateStruct":120,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":42},"100598512","sensory-profile-of-people-with-high-intellectual-potential-hip-100598512","NCT07072455","Sensory Profile of People With High Intellectual Potential (HIP)","Sensory Profile of People With High Intellectual Potential","HPIsens","Inclusion Criteria:\n\n* High Intellectual Potential:\n* Participants with a High Intellectual Potential : Cognitive assessment using the WAIS or WISC-V scale by a psychologist; Intelligence Quotient (IQ) ≥ 130, in the case of a homogeneous cognitive profile, or General Aptitude Index (GAI) \\> 130 \\[124-134\\], in the case of a heterogeneous cognitive profile\n* Gender and Age: Male or female, aged 18 to 65\n* Consent: Free, informed, and written consent (e-CRF)\n* Control :\n* Gender and Age: Male or female, aged 18 to 65\n* Consent: Free, informed, and written consent (e-CRF)\n\nExclusion Criteria:\n\n* High Intellectual Potential:\n* History or declared psychiatric disorder (characterized depressive episode, personality disorder, addiction, eating disorder, bipolar disorder, obsessive-compulsive disorder)\n* Neurodevelopmental disorders (autism spectrum disorder, attention deficit and hyperactivity disorder , developmental coordination disorder)\n* Sensory disability\n* Subjects under guardianship or curatorship\n* Pregnant or breast-feeding women\n* Control :\n* Presence of High Intellectual Potential known\n* Presence of intellectual development disorder\n* History or declared psychiatric disorder (characterized depressive episode, personality disorder, addiction, eating disorder, bipolar disorder, obsessive-compulsive disorder)\n* Neurodevelopmental disorders (autism spectrum disorder, attention deficit and hyperactivity disorder , developmental coordination disorder)\n* Sensory disability\n* Subjects under guardianship or curatorship\n* Pregnant or breast-feeding women","65 Years",{"count":110,"type":21},160,"This is a prospective observational psychology study on a non-clinical population, involving the use of questionnaires (non-interventional research).\n\nThis study involves the collection of data associated with High Intellectual Potential characteristics, sensory profile, and includes clinical measures such as anxiety anxiety, autistic traits and coping in High Intellectual Potential and control participants.",[113],"High Intellectual Potential",[113,115,116,82,117,118],"Sensory Profile","Coping Strategies","Sensory Processing","Autistic traits","2025-07-21",{"date":121,"type":34},"2025-07-24",{"date":123,"type":34},"2025-04-01",{"date":125,"type":21},"2027-04",{"name":40,"class":41},{"id":128,"slug":129,"hasResults":11,"nctId":130,"briefTitle":131,"officialTitle":131,"acronym":132,"eligibilityCriteria":133,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":108,"enrollmentInfo":134,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":136,"conditions":137,"keywords":142,"overallStatus":61,"whyStopped":4,"lastUpdateSubmitDate":144,"lastUpdatePostDateStruct":145,"startDateStruct":147,"completionDateStruct":149,"leadSponsor":151,"locationsCount":42},"100595329","exploratory-study-of-sensory-profile-and-coping-strategies-in-eating-disorders-100595329","NCT07031037","Exploratory Study of Sensory Profile and Coping Strategies in Eating Disorders","SensoryCop","Inclusion Criteria:\n\n* Gender and Age: Male or female, aged 18 to 65\n* Confirmed diagnosis of anorexia nervosa (F50.01; F50.02), boulimia nervosa (F50.2), hyperphagic episodes (F50.8) or restriction or avoidance of food intake (F50.8) according to DSM-5 criteria\n* Hospitalization or consultation for Eating Disorder at Centre Hospitalier Esquirol\n* Consent: Free, informed, and written consent, signed by the participant and\u002For their legal representative (for participants under protection measures) and the investigator (at the latest on the day of inclusion and before any research-related examination).\n\nExclusion Criteria:\n\n* Psychiatric comorbidity (non-tobacco addiction, characterized depressive episode, bipolar disorder, obsessive-compulsive disorder, schizophrenia and related disorders, neurodevelopmental disorder)\n* History of Eating Disorder other than current disorder\n* Proven sensory or neurological disability\n* Inability to understand questionnaires and information related to the study\n* Persons under psychiatric care in accordance with articles L. 3212-1 and L. 3213-1\n* Pregnant, nursing or parturient women\n* Adults subject to legal protection or unable to express their consent to express their consent\n* Persons not affiliated to a social security scheme or not benefiting from one social security scheme\n* Persons deprived of their liberty by judicial or administrative decision",{"count":135,"type":21},150,"This descriptive study aims primarily to characterize the sensory profile of patients with eating disorders (divided into three diagnostic groups: anorexia nervosa, boulimia nervosa and hyperphagia), controlling for possible autistic traits in this population.\n\nThe study involves measuring characteristics associated with eating disorders (diagnosis, BMI, anxiety), assessing the sensory profile (AASP), and coping strategies in patients with eating disorders who are hospitalised or followed up in consultation.",[138,139,140,141],"Eating Disorders","Anorexia Nervosa","Boulimia Nervosa","Hyperphagia",[115,116,138,143],"sensory processing disorder","2025-06-12",{"date":146,"type":34},"2025-06-22",{"date":148,"type":21},"2025-07",{"date":150,"type":21},"2028-07",{"name":40,"class":41},{"id":153,"slug":154,"hasResults":11,"nctId":155,"briefTitle":156,"officialTitle":156,"acronym":157,"eligibilityCriteria":158,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":108,"enrollmentInfo":159,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":161,"conditions":162,"keywords":166,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":168,"lastUpdatePostDateStruct":169,"startDateStruct":171,"completionDateStruct":173,"leadSponsor":175,"locationsCount":42},"100580642","sensory-profile-and-early-clinical-signs-of-calm-room-users-100580642","NCT06839950","Sensory Profile and Early Clinical Signs of Calm Room Users","EVAL-APAISE","Inclusion Criteria:\n\n* Gender and Age: Male or female, aged 18 to 65\n* Hospitalization: Admitted to the closed hospitalization unit for less than 10 days\n* Social security: Affiliated or beneficiary of a social security system\n* Consent: Free, informed, and written consent, signed by the participant and\u002For their legal representative (for participants under protection measures) and the investigator (at the latest on the day of inclusion and before any research-related examination).\n\nExclusion Criteria:\n\n* Inability to understand information related to the study\n* Proven sensory disability\n* Dementia\n* Pregnancy\n* Lack of social protection\n* Previous Participation in this research protocol (in the case of a new hospitalization)\n* Expression abilities incompatible with completing the AASP Scale (e.g., french language comprehension issues, mute individuals, patients in restraint and\u002For therapeutic isolation)",{"count":160,"type":21},80,"This descriptive study aims primarily to characterize the sensory profile of patients in a closed psychiatric hospital unit who use a calming room.\n\nThe main questions it aims to answer are :\n\n* Could sensory information processing disorders be the cause of distress and tension in these patients?\n* Could users of the calming room present extreme sensory processing profiles, characterized by either hypersensitivity or hyposensitivity ?\n\nParticipants will answer a survey to determine their the sensory profile. Participants can already use the calming room as part of their regular medical care and they will answer surveys before and after each use.",[163,164,165],"Psychotic Disorders","Personality Disorders","Mood Disorders",[167,163,115,165,164],"Calm room","2025-02-17",{"date":170,"type":34},"2025-02-21",{"date":172,"type":34},"2023-12-19",{"date":174,"type":21},"2028-05-19",{"name":40,"class":41},{"id":177,"slug":178,"hasResults":11,"nctId":179,"briefTitle":180,"officialTitle":181,"acronym":182,"eligibilityCriteria":183,"healthyVolunteers":11,"sex":17,"minAge":184,"maxAge":185,"enrollmentInfo":186,"targetDuration":4,"studyType":53,"phases":187,"briefSummary":188,"conditions":189,"keywords":191,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":168,"lastUpdatePostDateStruct":197,"startDateStruct":199,"completionDateStruct":201,"leadSponsor":203,"locationsCount":42},"100534080","impact-of-psychomotor-therapy-on-the-quality-of-life-in-depression-100534080","NCT06234176","Impact of Psychomotor Therapy on the Quality of Life in Depression","Influence of Psychomotor Therapy on Quality of Life in Patients With a Major Depressive Disorder: a Randomized Controlled Trial","PsyMot-Dep","Inclusion Criteria:\n\n* Diagnosis of depressive episode according to DSM-5 criteria.\n* HDRS \\> 16\n* Hospitalized or followed-up in one of the participating centers.\n* Affiliated or beneficiary of a social security scheme.\n* Free, informed and written consent signed by the participant and the investigator (no later than the day of inclusion and before any examination required by the research).\n\nExclusion Criteria:\n\n* Psychiatric comorbidity (non-tobacco addiction, eating disorders, bipolar disorder, obsessive-compulsive disorder, schizophrenia and related disorders)\n* Sensory impairment or proven neurological pathology\n* History of neurological brain damage (including stroke, tumor, trauma resulting in loss of consciousness lasting more than 10 minutes)\n* Limited functional ability (difficulty in moving about, performing manual tasks or moving about)\n* Inability to understand questionnaires and study information\n* Inability to travel to the inclusion center (personal vehicle, public transport)\n* Pregnant or breast-feeding women, on declaration\n* Forced hospitalization, subjects under guardianship or trusteeship, lack of social protection","20 Years","60 Years",{"count":52,"type":21},[55],"The effectiveness of psychomotor therapy in improving clinical outcomes or quality of life for individuals with depression is unclear.\n\nThe investigators will assess how the participants' quality of life and psychomotor profile change over time.\n\nThe study aims to compare the quality of life at 3 months between patients who received 3 months of personalised psychomotor therapy in addition to standard treatment and those who received standard treatment alone.\n\nThe study lasted for 6 months, and the investigators expects a total of 128 people to participate in this research across several hospital establishments. This study evaluates the effectiveness of two types of treatment, divided into two randomly selected groups.\n\nTo participate, individuals must have a medical diagnosis of major depressive disorder (MDD) and be between the ages of 20 and 60.\n\nThey must have depressive symptoms with an HDRS score greater than 16 and provide informed consent. They must be treated or hospitalised at the Centre Hospitalier Esquirol or the Centre Hospitalier Henri Laborit (France).\n\nAfter providing consent, they will undergo an initial clinical interview that evaluates anxiety, self-esteem, pleasure, and quality of life. The therapist assessed the participant's muscle tone, gross motor skills, praxis, manual dexterity, rhythm, processing of sensory information, and body image.\n\nFollowing the assessment, the participant was randomly assigned to either the experimental or control group.\n\nThe experimental group received the usual treatment for depression and underwent psychomotor therapy once a week for 12 weeks.\n\nThe control group received the standard treatment for depression and underwent weekly telephone interviews.\n\nAn assessment is scheduled at 1 month to evaluate the participant's health status, including any changes to treatment and assessment of anxiety and depressive symptoms.\n\nAnother interim check-up is scheduled at 3 months to assess the patient's health status. The interview will also assess any changes to treatment, anxiety and depressive symptoms, quality of life, and psychomotor function.\n\nA final visit will be scheduled at 6 months for an assessment of the participant's health. The interview will also assess any changes to treatment, anxiety and depressive symptoms, quality of life, and psychomotor function.",[190],"Major Depressive Disorder",[192,193,194,195,196],"psychomotor therapy","quality of life","major depressive disorder","psychomotor profile","sensory processing",{"date":198,"type":34},"2025-02-19",{"date":200,"type":34},"2024-04-01",{"date":202,"type":21},"2026-08",{"name":40,"class":41},""]